An impaired renal function: A predictor of ventricular arrhythmia and mortality in patients with nonischemic cardiomyopathy and heart failure

PACE - Pacing and Clinical Electrophysiology

Volumn 34, Issue 7, 2011, Pages 894-899

  Kreuz, Jens ^a   Horlbeck, Fritz ^a   Hoyer, Felix ^a   Mellert, Fritz ^a   Fimmers, Rolf ^a   Lickfett, Lars ^a   Nickenig, Georg ^a   Schwab, Joerg O ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

Congestive heart failure; Implantable cardioverter defibrillator; Noninvasive risk assessment tests; VT

Indexed keywords

CREATININE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

ADULT; AGED; ARTICLE; CARDIAC PATIENT; CARDIOVASCULAR RISK; COHORT ANALYSIS; CREATININE BLOOD LEVEL; DEFIBRILLATOR; FEMALE; HEART FAILURE; HEART VENTRICLE TACHYCARDIA; HUMAN; INCIDENCE; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; NONISCHEMIC CARDIOMYOPATHY;

AGED; CARDIOMYOPATHIES; FEMALE; HEART FAILURE; HUMANS; INCIDENCE; KIDNEY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RETROSPECTIVE STUDIES; RISK FACTORS; TACHYCARDIA, VENTRICULAR;

EID: 84860408174     PISSN: 01478389     EISSN: 15408159     Source Type: Journal    
DOI: 10.1111/j.1540-8159.2011.03059.x     Document Type: Article

References (19)

1. Moss AJ, Zareba W, Hall WJ, Klein H, Wilber DJ, Cannom DS, Daubert JP, et al. Prophylactic implantation of a defibrillator in patients with myocardial infarction and reduced ejection fraction. N Engl J Med 2002;346:877-883. (Pubitemid 34984635)
2. Buxton AE, Lee KL, Fisher JD, Josephson ME, Prystowsky EN, Hafley G. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter unsustained tachycardia trial investigators. N Engl J Med 1999;341:1882-1890.
3. Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, Domanski M. Amiodarone or an implantable cardioverterdefibrillator for congestive heart failure. N Engl J Med 2005;352:225-237. (Pubitemid 40110811)
4. Kadish A, Dyer A, Daubert JP, Quigg R, Estes NA, Anderson KP, Calkins H, et al. Prophylactic defibrillator implantation in patients with nonischemic dilated cardiomyopathy. N Engl J Med 2004;350:2151-2158. (Pubitemid 38637995)
5. Goldberger JJ, Subacius H, Schaechter A, Howard A, Berger R, Shalaby A, Levine J, et al. DEFINITE Investigators. Effects of statin therapy on arrhythmic events and survival in patients with nonischemic dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1228-1233. (Pubitemid 44363151)
6. Daubert JP, Winters SL, Subacius H, Berger RD, Ellenbogen KA, Taylor SG, Schaechter A, et al. Defibrillators in nonischemic cardiomyopathy treatment evaluation (DEFINITE) Investigators. Ventricular arrhythmia inducibility predicts subsequent ICD activation in nonischemic cardiomyopathy patients: A DEFINITE substudy. Pacing Clin Electrophysiol 2009;32:755-761.
7. Brilakis ES, Friedman PA, Maounis TN, Rokas SG, Shen WK, Stamatelopoulos SF, Cokkinos DV. Programmed ventricular stimulation in patients with idiopathic dilated cardiomyopathy and syncope receiving implantable cardioverter- defibrillators: A case series and a systematic review of the literature. Int J Cardiol 2005;98:395-401. (Pubitemid 40247927)
8. Brilakis ES, Shen WK, Hammill SC, Hodge DO, Rea RF, Lexvold NY, Friedman PA. Role of programmed ventricular stimulation and implantable cardioverter defibrillators in patients with idiopathic dilated cardiomyopathy and syncope. Pacing Clin Electrophysiol 2001;24:1623-1630. (Pubitemid 33065521)
9. Grimm W, Hoffmann J, Menz V, Luck K, Maisch B. Programmed ventricular stimulation for arrhythmia risk prediction in patients with idiopathic dilated cardiomyopathy and nonsustained ventricular tachycardia. J Am Coll Cardiol 1998;32:739-745. (Pubitemid 28435263)
10. Albert CM, Quigg R, Saba S, Estes NA 3rd, Shaechter A, Subacius H, Howard A, et al. DEFINITE Investigators. Sex differences in outcome after implantable cardioverter defibrillator implantation in nonischemic cardiomyopathy. Am Heart J 2008;156:367-372. (Pubitemid 352037423)
11. Zareba W, Moss AJ, Jackson HW, Wilber DJ, Ruskin JN, McNitt S, Brown M, et al. Clinical course and implantable cardioverter defibrillator therapy in postinfarction women with severe left ventricular dysfunction. J Cardiovasc Electrophysiol 2005;16:1265-1270.
12. Rankovic V, Karha J, Passman R, Kadish AH, Goldberger JJ. Predictors of appropriate implantable cardioverter-defibrillator therapy in patients with idiopathic dilated cardiomyopathy. Am J Cardiol 2002;89:1072-1076. (Pubitemid 34462853)
13. Grimm W, Christ M, Bach J, Müller HH, Maisch B. Noninvasive arrhythmia risk stratification in idiopathic dilated cardiomyopathy: Results of the Marburg Cardiomyopathy Study. Circulation 2003;108:2883-2891. (Pubitemid 37517816)
14. Karaoguz R, Maydanozcu S, Altun T, Güldal M, Akyürek O, Erol C. Appropriate ICD therapy in patients with idiopathic dilated cardiomyopathy: Long term follow-up. Int Heart J 2006;47:763-773. (Pubitemid 44768727)
15. Domanski M, Coady S, Fleg J, Tian X, Sachdev V. Effect of statin therapy on survival in patients with nonischemic dilated cardiomyopathy (from the betablocker Evaluation of Survival Trial [BEST]). Am J Cardiol 2007;99:1448-1450. (Pubitemid 46686650)
16. Dickinson MG, Ip JH, Olshansky B, Hellkamp AS, Anderson J, Poole JE, Mark DB, et al. Statin use was associated with reduced mortality in both ischemic and nonischemic cardiomyopathy and in patients with implantable defibrillators: Mortality data and mechanistic insights from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Am Heart J 2007;153:573-578. (Pubitemid 46440697)
17. Takahashi A, Shiga T, Shoda M, Manaka T, Ejima K, Hagiwara N. Impact of renal dysfunction on appropriate therapy in implantable cardioverter defibrillator patients with nonischaemic dilated cardiomyopathy. Europace 2009;11:1476-1482.
18. Cuculich PS, Sánchez JM, Kerzner R, Greenberg SL, Sengupta J, Chen J, Faddis MN, et al. Poor prognosis for patients with chronic kidney disease despite ICD therapy for the primary prevention of sudden death. Pacing Clin Electrophysiol 2007;30:207-213. (Pubitemid 46333676)
19. Amin MS, Fox AD, Kalahasty G, Shepard RK, Wood MA, Ellenbogen KA. Benefit of primary prevention implantable cardioverterdefibrillators in the setting of chronic kidney disease: A decision model analysis. J Cardiovasc Electrophysiol 2008;19:1275-1280.